Endoscopic therapy of biliary strictures post living donor

36
ENDOSCOPIC THERAPY OF BILIARY STRICTURES POST LIVING DONOR LIVER TRANSPLANT Presented by Dr Zubin Sharma Moderated by Dr Rajesh Puri

Transcript of Endoscopic therapy of biliary strictures post living donor

Page 1: Endoscopic therapy of biliary strictures post living donor

ENDOSCOPIC THERAPY OF BILIARY STRICTURES

POST LIVING DONOR LIVER TRANSPLANT

Presented byDr Zubin Sharma

Moderated by

Dr Rajesh Puri

Page 2: Endoscopic therapy of biliary strictures post living donor

Introduction

From 1960s, Liver Transplantation has evolved into a standard of care for end stage liver disease

The Biliary complications still remain the Achillis heel.

Affect graft survival, has serious effects on lifestyle of patients, an important cause of morbidity and mortality.

Page 3: Endoscopic therapy of biliary strictures post living donor

Introduction

Endoscopic therapy now the treatment of choice

Surgery remains a second choice for most of these patients

Page 4: Endoscopic therapy of biliary strictures post living donor

Incidence Biliary tract complications after OLT stand around 11-

25%

Includes leaks, strictures, casts, sludge, stones and sphincter of Oddi dysfunction

Biliary epithelium liable to ischemic damage

The reported incidence of biliary strictures is 5%-15% after deceased donor liver transplantation (DDLT)

28%-32% after right-lobe live donor liver transplantation (LDLT).

Page 5: Endoscopic therapy of biliary strictures post living donor

Incidence- Literature Review

Page 6: Endoscopic therapy of biliary strictures post living donor

Incidence- Literature Review

Page 7: Endoscopic therapy of biliary strictures post living donor

Anatomy of Bile Ducts

Huang Classification is widely used for variations in bile duct.

Right Hepatic duct is present in 65% of all cases

Page 8: Endoscopic therapy of biliary strictures post living donor
Page 9: Endoscopic therapy of biliary strictures post living donor

Vascular Supply of Biliary tract Most vulnerable point of biliary system Liver parenchyma- Dual Blood Supply (Portal Vein and

Hepatic Artery) Biliary Tract- only Arterial supply The common bile duct is supplied via two main

arteries running at the right and left border of the bile duct , the "3 o' clock“ and "9 o' clock“ arteries, which

variably arise from the retroportal, retroduodenal or gastroduodenal arteries and communicate with the right or less often with the left hepatic artery

Severe hypotension can lead to Ischaemic cholangiopathy

Page 10: Endoscopic therapy of biliary strictures post living donor

Vascular Supply

Page 11: Endoscopic therapy of biliary strictures post living donor

Vascular Supply of Biliary tract

Approximately 60% of the arterial perfusion comes from the gastroduodenal, and only 30–40% downward from the hepatic artery

The hilar and intrahepatic ducts are nourished by the peribiliary vascular plexus, a network of capillaries arising from the terminal arterial branches

Page 12: Endoscopic therapy of biliary strictures post living donor

Types/Classification Broadly divided into

Anastomotic Strictures (AS)Non- Anastomotic Strictures (NAS)

The 2 types of strictures cannot be compared as they have inherent differences in their pathology, time to presentation, treatment, and response to treatment

Page 13: Endoscopic therapy of biliary strictures post living donor

Types/Classification NAS account for 10% to 25% of all stricture

complications after orthotopic liver transplantation, with an incidence of 1% to 19%;

These are often multiple, longer and occur earlier than anastomotic strictures.

AS, on the other hand, are isolated, are localized to the site of the anastomosis, and are short in length.

Their reported incidence in the modern literature is 4% to 9%.

Page 14: Endoscopic therapy of biliary strictures post living donor

Types/Classification

Ling Classification- Based on endoscopic pictures after LT.

Page 15: Endoscopic therapy of biliary strictures post living donor
Page 16: Endoscopic therapy of biliary strictures post living donor
Page 17: Endoscopic therapy of biliary strictures post living donor

Pathogenesis and Risk Factors

Anastomotic Strictures-EARLYIschemia and Fibrosis secondary to

suboptimal surgical techniqueSmall Caliber of bile ductsSize mismatchInappropriate suture materialTension at anastomosisExcessive use of electrocautery

Page 18: Endoscopic therapy of biliary strictures post living donor

Pathogenesis and Risk Factors

Anastomotic Strictures- LATEIschemia at the end of donor or recipient

ductUse of T-Tube??LDLT vs DDLTDuct to Duct anastomosis vs

hepaticojejunostomy

Page 19: Endoscopic therapy of biliary strictures post living donor

Pathogenesis and Risk FactorsNon-Anastomotic Strictures (NAS)

Moench et al. proposed a classification NAS secondary to macroangiopathyNAS secondary to microangiopathy

(preservation injury, prolonged cold and warm ischemia times, donation after cardiac death, and prolonged use of vasopressors in the donor)LATE- Immunogenicity (chronic rejection, ABO incompatibility, autoimmune hepatitis, and pri-mary sclerosing cholangitis

Hepatitis C and cytomegalovirus

Page 20: Endoscopic therapy of biliary strictures post living donor

Non-Anastomotic Strictures (NAS)Further Classifications

Buis et al. Have suggested a classification of the involved intrahepatic zones A t o D

Hilar bifurcation(zone A), ducts between the first and second-order branches(B), between second and third order branches (C) and in the periphery of the liver(D)

Page 21: Endoscopic therapy of biliary strictures post living donor
Page 22: Endoscopic therapy of biliary strictures post living donor

Risk Factors in LDLT Presence of Bile leaks- an important predictor-

Bile induced inflammation Hwang et al- showed small duct size as risk

factor- not confirmed in subsequent studies Multiple duct anastomosis Recent meta-analysis showed older donor age

and presence of bile leaks in post operative period as the only statistically significant risk factors.

Use of UW solution- increased ischemia of biliary arteries.

Increased Cold Ischemia time >11.5 hours

Page 23: Endoscopic therapy of biliary strictures post living donor

Presentation Patients may be asymptomatic at presentation, with

elevations of serum aminotransferases, bilirubin, alkaline phosphatase and/or gamma-glutamyl transferase levels.

A high index of suspicion must be maintained, as pain may be absent in the transplant setting because of immunosuppression and hepatic denervation

A recent report of 15 patients highlighted the use of serum bilirubin >1.5 mg/dL as a better indirect marker of biliary stasis in living donor liver transplantation (LDLT) than alkaline phosphatase, which is overly sensitive

Page 24: Endoscopic therapy of biliary strictures post living donor

Diagnosis

Liver ultrasound (US) with Doppler evaluation of the hepatic vessels.

Lack of correlation between the ducal dilatation on the ultrasound and the cholangiographic and clinical features.

It is not clear why the donor bile ducts do not respond to distal obstruction by displaying the same degree of proportional dilation as non transplanted livers

Page 25: Endoscopic therapy of biliary strictures post living donor

Diagnosis

99-technetium labeled iminodiacetic acid identifies strictures with 75% sensitivity and 100% specificity.

MRCP is currently considered an optimal noninvasive diagnostic tool for the assessment of biliary complications after orthotopic liver transplantation.

Cholangiography is considered by all to be the gold standard.

Page 26: Endoscopic therapy of biliary strictures post living donor

MANAGMENT AS

Endoscopic treatment consists of identification of the opening of the stricture followed by cannulation by the guidewire, balloon dilatation of the stricture, and subsequent placement of plastic stents.

Balloon dilation alone without stent placement is only successful in approximately 40% of cases.

Balloon dilation with additional stent placement appears to be more successful with a durable outcome in 75% of patients with anastomotic strictures

Page 27: Endoscopic therapy of biliary strictures post living donor

MANAGMENT AS

Replaced by larger stents every 3 month to prevent the complication of clogging, cholangitis, or stone formation.

Dual or multiple stents, by providing greater dilatation, have shown better results than single stents

Most patients with anastomotic strictures require ongoing ERCP sessions every 3 month with balloon dilation of 6 to 10 mm and multiple stents of 7 Fr to 10 Fr repeated for 12 to 24 months.

Page 28: Endoscopic therapy of biliary strictures post living donor
Page 29: Endoscopic therapy of biliary strictures post living donor

MANAGMENT

ASAn increasing number of stents can be used

at each session to achieve a maximum diameter.

The treatment is usually completed in 1 year with an average of 3 to 4 stent exchange sessions

Endoscopic treatment success rates in AS after LDLT appears significantly less than AS for DDLT at 37% to 71%

Page 30: Endoscopic therapy of biliary strictures post living donor

MANAGMENT AS

There is some experience in temporary placement of covered self-expanding metal stents to reduce the need for repeated stent exchanges but long term results not identified.

In the few situations when endoscopic access to the AS is not obtainable, as in Roux-en-Y reconstructions,- Combined approach

A percutaneous transhepatic route followed by “rendezvous” endoscopy

Surgical revision and biliary reconstruction with the formation of a hepaticojejunostomy is indicated when endoscopic or percutaneous treatment fails.

Page 31: Endoscopic therapy of biliary strictures post living donor

MANAGMENT

NASManagement of patients with NAS is difficult,

and any generalized treatment recommendations are difficult to make.

Accumulation of biliary sludge and casts renders therapy particularly difficult because of rapid stent occlusion.

NAS are more resistant to endoscopic treatment, the results of endoscopic approaches have been particularly disappointing in the context of NAS in LDLT

Page 32: Endoscopic therapy of biliary strictures post living donor

MANAGMENT NAS

The average success rate in LDLT varies from 25% to 33%

Endoscopic therapy of non-anastomotic strictures typically consists of extraction of the biliary sludge and casts and balloon dilation of all accessible strictures followed by placement of plastic stents with replacement every 3 month.

Patients with NAS may required early retransplantation, endoscopic therapy appears to play a more prominent role as a bridge to liver retransplantation

Page 33: Endoscopic therapy of biliary strictures post living donor

ENDOSCOPY PROTOCOL

Page 34: Endoscopic therapy of biliary strictures post living donor
Page 35: Endoscopic therapy of biliary strictures post living donor

FUTURE DIRECTIONS SPYGLASS Direct Visualization System Peripheral cutting balloons may be more

effective in benign biliary stricture not responsive to standard measures

Self-expanding stents made of bioabsorbable material may offer several advantages compared to the plastic and self-expanding metal stents

Bioabsorbable stents can be impregnated with pharmaceutical compounds, such as antimicrobial and antineoplastic agents

Page 36: Endoscopic therapy of biliary strictures post living donor

Thank You….